{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:33:34Z","timestamp":1764509614040},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Hippo signalling pathway plays very important roles in tumorigenesis, metastasis, organ size control, and drug resistance. Although, it has been shown that the two major components of Hippo pathway, YAP and TAZ, play very crucial role in tumorigenesis and drug resistance, the exact molecular mechanisms are still unknown. Recently, we have shown that the prolyl isomerase Pin1 regulates the activity of Hippo pathway through interaction with Hippo component LATS kinase. Thus we asked if Pin1 is also able to interact with other Hippo pathway components. Therefore, in order to investigate whether Pin1 can interacts with other components of the Hippo pathway, we performed GST-pull down and co-immunoprecipitation (Co-IP) assays and have identified two Hippo components YAP and TAZ oncoproteins as novel binding partner of Pin1. We found that Pin1 interacts with YAP\/TAZ in a phosphorylation-independent manner and WW domain of Pin1 is necessary for this interaction. Moreover, by using real time qRT-PCR, Cycloheximide chase, luciferase reporter, cell viability and soft agar assays, we have shown that Pin1 increases the tumorigenic and drug-resistant activity of YAP\/TAZ through stabilization of YAP\/TAZ at protein levels. Together, we have identified Pin1 as a novel positive regulator of YAP\/TAZ in tumorigenesis and drug resistance of breast cancer cells. These findings will provide a significant contribution for targeting the Pin1-YAP\/TAZ signaling for the successful treatment of tumorigenesis and drug resistance of breast and other cancers in the future.<\/jats:p>","DOI":"10.1038\/s41598-019-42767-w","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T10:04:03Z","timestamp":1556013843000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Identification of Prolyl isomerase Pin1 as a novel positive regulator of YAP\/TAZ in breast cancer cells"],"prefix":"10.1038","volume":"9","author":[{"given":"Prem","family":"Khanal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,23]]},"reference":[{"key":"42767_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A. et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians 65, 87\u2013108, https:\/\/doi.org\/10.3322\/caac.21262 (2015).","journal-title":"CA: a cancer journal for clinicians"},{"key":"42767_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-0-387-74039-3_1","volume":"608","author":"AM Gonzalez-Angulo","year":"2007","unstructured":"Gonzalez-Angulo, A. M., Morales-Vasquez, F. & Hortobagyi, G. N. Overview of resistance to systemic therapy in patients with breast cancer. Advances in experimental medicine and biology 608, 1\u201322 (2007).","journal-title":"Advances in experimental medicine and biology"},{"key":"42767_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.15171\/apb.2017.041","volume":"7","author":"B Mansoori","year":"2017","unstructured":"Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S. & Baradaran, B. The Different Mechanisms of Cancer Drug Resistance: A Brief Review. Advanced pharmaceutical bulletin 7, 339\u2013348, https:\/\/doi.org\/10.15171\/apb.2017.041 (2017).","journal-title":"Advanced pharmaceutical bulletin"},{"key":"42767_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean, M., Fojo, T. & Bates, S. Tumour stem cells and drug resistance. Nature reviews. Cancer 5, 275\u2013284, https:\/\/doi.org\/10.1038\/nrc1590 (2005).","journal-title":"Nature reviews. Cancer"},{"key":"42767_CR5","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1200\/JCO.2014.55.4139","volume":"32","author":"GW Sledge","year":"2014","unstructured":"Sledge, G. W. et al. Past, present, and future challenges in breast cancer treatment. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 32, 1979\u20131986, https:\/\/doi.org\/10.1200\/JCO.2014.55.4139 (2014).","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"42767_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3816\/CBC.2008.n.025","volume":"8","author":"SE Jones","year":"2008","unstructured":"Jones, S. E. Metastatic breast cancer: the treatment challenge. Clinical breast cancer 8, 224\u2013233, https:\/\/doi.org\/10.3816\/CBC.2008.n.025 (2008).","journal-title":"Clinical breast cancer"},{"key":"42767_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0962-8924(02)02253-5","volume":"12","author":"KP Lu","year":"2002","unstructured":"Lu, K. P., Liou, Y. C. & Zhou, X. Z. Pinning down proline-directed phosphorylation signaling. Trends in cell biology 12, 164\u2013172 (2002).","journal-title":"Trends in cell biology"},{"key":"42767_CR8","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nrm2261","volume":"8","author":"KP Lu","year":"2007","unstructured":"Lu, K. P. & Zhou, X. Z. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nature reviews. Molecular cell biology 8, 904\u2013916, https:\/\/doi.org\/10.1038\/nrm2261 (2007).","journal-title":"Nature reviews. Molecular cell biology"},{"key":"42767_CR9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ni.2069","volume":"12","author":"A Tun-Kyi","year":"2011","unstructured":"Tun-Kyi, A. et al. Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity. Nature immunology 12, 733\u2013741, https:\/\/doi.org\/10.1038\/ni.2069 (2011).","journal-title":"Nature immunology"},{"key":"42767_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.tibs.2011.07.001","volume":"36","author":"YC Liou","year":"2011","unstructured":"Liou, Y. C., Zhou, X. Z. & Lu, K. P. Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends in biochemical sciences 36, 501\u2013514, https:\/\/doi.org\/10.1016\/j.tibs.2011.07.001 (2011).","journal-title":"Trends in biochemical sciences"},{"key":"42767_CR11","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1038\/onc.2011.548","volume":"31","author":"P Khanal","year":"2012","unstructured":"Khanal, P. et al. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells. Oncogene 31, 3845\u20133856, https:\/\/doi.org\/10.1038\/onc.2011.548 (2012).","journal-title":"Oncogene"},{"key":"42767_CR12","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0002-9440(10)63731-5","volume":"164","author":"L Bao","year":"2004","unstructured":"Bao, L. et al. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. The American journal of pathology 164, 1727\u20131737, https:\/\/doi.org\/10.1016\/S0002-9440(10)63731-5 (2004).","journal-title":"The American journal of pathology"},{"key":"42767_CR13","doi-asserted-by":"publisher","first-page":"23829","DOI":"10.1074\/jbc.M109.092874","volume":"285","author":"GM Namgoong","year":"2010","unstructured":"Namgoong, G. M. et al. The prolyl isomerase Pin1 induces LC-3 expression and mediates tamoxifen resistance in breast cancer. The Journal of biological chemistry 285, 23829\u201323841, https:\/\/doi.org\/10.1074\/jbc.M109.092874 (2010).","journal-title":"The Journal of biological chemistry"},{"key":"42767_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.molcel.2012.04.012","volume":"46","author":"SH Min","year":"2012","unstructured":"Min, S. H. et al. Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase. Molecular cell 46, 771\u2013783, https:\/\/doi.org\/10.1016\/j.molcel.2012.04.012 (2012).","journal-title":"Molecular cell"},{"key":"42767_CR15","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1128\/MCB.26.4.1463-1479.2006","volume":"26","author":"F Suizu","year":"2006","unstructured":"Suizu, F., Ryo, A., Wulf, G., Lim, J. & Lu, K. P. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis. Molecular and cellular biology 26, 1463\u20131479, https:\/\/doi.org\/10.1128\/MCB.26.4.1463-1479.2006 (2006).","journal-title":"Molecular and cellular biology"},{"key":"42767_CR16","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1096\/fj.13-236851","volume":"27","author":"P Khanal","year":"2013","unstructured":"Khanal, P. et al. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 27, 4606\u20134618, https:\/\/doi.org\/10.1096\/fj.13-236851 (2013).","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"42767_CR17","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1158\/1535-7163.MCT-09-0560","volume":"9","author":"P Khanal","year":"2010","unstructured":"Khanal, P., Namgoong, G. M., Kang, B. S., Woo, E. R. & Choi, H. S. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase\/extracellular signal-regulated kinase kinase 1. Molecular cancer therapeutics 9, 606\u2013616, https:\/\/doi.org\/10.1158\/1535-7163.MCT-09-0560 (2010).","journal-title":"Molecular cancer therapeutics"},{"key":"42767_CR18","first-page":"1409","volume":"34","author":"HJ Yun","year":"2014","unstructured":"Yun, H. J., Kim, J. Y., Kim, G. & Choi, H. S. Prolyl-isomerase Pin1 impairs trastuzumab sensitivity by up-regulating fatty acid synthase expression. Anticancer research 34, 1409\u20131416 (2014).","journal-title":"Anticancer research"},{"key":"42767_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/ijc.29457","volume":"138","author":"B Yeung","year":"2016","unstructured":"Yeung, B., Yu, J. & Yang, X. Roles of the Hippo pathway in lung development and tumorigenesis. International journal of cancer 138, 533\u2013539, https:\/\/doi.org\/10.1002\/ijc.29457 (2016).","journal-title":"International journal of cancer"},{"key":"42767_CR20","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","volume":"130","author":"J Dong","year":"2007","unstructured":"Dong, J. et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120\u20131133, https:\/\/doi.org\/10.1016\/j.cell.2007.07.019 (2007).","journal-title":"Cell"},{"key":"42767_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","volume":"19","author":"D Pan","year":"2010","unstructured":"Pan, D. The hippo signaling pathway in development and cancer. Developmental cell 19, 491\u2013505, https:\/\/doi.org\/10.1016\/j.devcel.2010.09.011 (2010).","journal-title":"Developmental cell"},{"key":"42767_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ceb.2016.08.004","volume":"43","author":"IM Moya","year":"2016","unstructured":"Moya, I. M. & Halder, G. The Hippo pathway in cellular reprogramming and regeneration of different organs. Current opinion in cell biology 43, 62\u201368, https:\/\/doi.org\/10.1016\/j.ceb.2016.08.004 (2016).","journal-title":"Current opinion in cell biology"},{"key":"42767_CR23","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1158\/0008-5472.CAN-10-2711","volume":"71","author":"D Lai","year":"2011","unstructured":"Lai, D., Ho, K. C., Hao, Y. & Yang, X. Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer research 71, 2728\u20132738, https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2711 (2011).","journal-title":"Cancer research"},{"key":"42767_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrc3876","volume":"15","author":"T Moroishi","year":"2015","unstructured":"Moroishi, T., Hansen, C. G. & Guan, K. L. The emerging roles of YAP and TAZ in cancer. Nature reviews. Cancer 15, 73\u201379, https:\/\/doi.org\/10.1038\/nrc3876 (2015).","journal-title":"Nature reviews. Cancer"},{"key":"42767_CR25","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1128\/MCB.01874-07","volume":"28","author":"QY Lei","year":"2008","unstructured":"Lei, Q. Y. et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Molecular and cellular biology 28, 2426\u20132436, https:\/\/doi.org\/10.1128\/MCB.01874-07 (2008).","journal-title":"Molecular and cellular biology"},{"key":"42767_CR26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/ncb1748","volume":"10","author":"X Varelas","year":"2008","unstructured":"Varelas, X. et al. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nature cell biology 10, 837\u2013848, https:\/\/doi.org\/10.1038\/ncb1748 (2008).","journal-title":"Nature cell biology"},{"key":"42767_CR27","doi-asserted-by":"publisher","first-page":"13355","DOI":"10.1074\/jbc.M900843200","volume":"284","author":"H Zhang","year":"2009","unstructured":"Zhang, H. et al. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. The Journal of biological chemistry 284, 13355\u201313362, https:\/\/doi.org\/10.1074\/jbc.M900843200 (2009).","journal-title":"The Journal of biological chemistry"},{"key":"42767_CR28","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.cellsig.2013.05.002","volume":"25","author":"D Lai","year":"2013","unstructured":"Lai, D. & Yang, X. BMP4 is a novel transcriptional target and mediator of mammary cell migration downstream of the Hippo pathway component TAZ. Cellular signalling 25, 1720\u20131728, https:\/\/doi.org\/10.1016\/j.cellsig.2013.05.002 (2013).","journal-title":"Cellular signalling"},{"key":"42767_CR29","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1038\/onc.2010.606","volume":"30","author":"Z Zhou","year":"2011","unstructured":"Zhou, Z. et al. TAZ is a novel oncogene in non-small cell lung cancer. Oncogene 30, 2181\u20132186, https:\/\/doi.org\/10.1038\/onc.2010.606 (2011).","journal-title":"Oncogene"},{"key":"42767_CR30","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1158\/0008-5472.CAN-07-2696","volume":"68","author":"SW Chan","year":"2008","unstructured":"Chan, S. W. et al. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer research 68, 2592\u20132598, https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-2696 (2008).","journal-title":"Cancer research"},{"key":"42767_CR31","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ejca.2011.10.001","volume":"48","author":"X Wang","year":"2012","unstructured":"Wang, X., Su, L. & Ou, Q. Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer. European journal of cancer 48, 1227\u20131234, https:\/\/doi.org\/10.1016\/j.ejca.2011.10.001 (2012).","journal-title":"European journal of cancer"},{"key":"42767_CR32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/onc.2014.5","volume":"34","author":"M Bartucci","year":"2015","unstructured":"Bartucci, M. et al. TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells. Oncogene 34, 681\u2013690, https:\/\/doi.org\/10.1038\/onc.2014.5 (2015).","journal-title":"Oncogene"},{"key":"42767_CR33","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1158\/0008-5472.CAN-13-2712","volume":"74","author":"Y Zhao","year":"2014","unstructured":"Zhao, Y. et al. YAP-induced resistance of cancer cells to antitubulin drugs is modulated by a Hippo-independent pathway. Cancer research 74, 4493\u20134503, https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2712 (2014).","journal-title":"Cancer research"},{"key":"42767_CR34","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1074\/jbc.M709037200","volume":"283","author":"Y Hao","year":"2008","unstructured":"Hao, Y., Chun, A., Cheung, K., Rashidi, B. & Yang, X. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. The Journal of biological chemistry 283, 5496\u20135509, https:\/\/doi.org\/10.1074\/jbc.M709037200 (2008).","journal-title":"The Journal of biological chemistry"},{"key":"42767_CR35","doi-asserted-by":"publisher","unstructured":"Lo Sardo, F., Strano, S. & Blandino, G. YAP and TAZ In Lung Cancer: Oncogenic Role and Clinical Targeting. Cancers 10, https:\/\/doi.org\/10.3390\/cancers10050137 (2018).","DOI":"10.3390\/cancers10050137"},{"key":"42767_CR36","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1158\/1541-7786.MCR-17-0593","volume":"16","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y. et al. PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways. Molecular cancer research: MCR 16, 1046\u20131058, https:\/\/doi.org\/10.1158\/1541-7786.MCR-17-0593 (2018).","journal-title":"Molecular cancer research: MCR"},{"key":"42767_CR37","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1158\/1541-7786.MCR-17-0684","volume":"16","author":"B Yeung","year":"2018","unstructured":"Yeung, B., Khanal, P., Mehta, V., Trinkle-Mulcahy, L. & Yang, X. Identification of Cdk1-LATS-Pin1 as a Novel Signaling Axis in Anti-tubulin Drug Response of Cancer Cells. Molecular cancer research: MCR 16, 1035\u20131045, https:\/\/doi.org\/10.1158\/1541-7786.MCR-17-0684 (2018).","journal-title":"Molecular cancer research: MCR"},{"key":"42767_CR38","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1126\/science.283.5406.1325","volume":"283","author":"PJ Lu","year":"1999","unstructured":"Lu, P. J., Zhou, X. Z., Shen, M. & Lu, K. P. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 283, 1325\u20131328 (1999).","journal-title":"Science"},{"key":"42767_CR39","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/380544a0","volume":"380","author":"KP Lu","year":"1996","unstructured":"Lu, K. P., Hanes, S. D. & Hunter, T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380, 544\u2013547, https:\/\/doi.org\/10.1038\/380544a0 (1996).","journal-title":"Nature"},{"key":"42767_CR40","doi-asserted-by":"publisher","first-page":"6778","DOI":"10.1093\/emboj\/19.24.6778","volume":"19","author":"F Kanai","year":"2000","unstructured":"Kanai, F. et al. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. The EMBO journal 19, 6778\u20136791, https:\/\/doi.org\/10.1093\/emboj\/19.24.6778 (2000).","journal-title":"The EMBO journal"},{"key":"42767_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/2045-3701-3-33","volume":"3","author":"X Guo","year":"2013","unstructured":"Guo, X. & Zhao, B. Integration of mechanical and chemical signals by YAP and TAZ transcription coactivators. Cell &. bioscience 3, 33, https:\/\/doi.org\/10.1186\/2045-3701-3-33 (2013).","journal-title":"bioscience"},{"key":"42767_CR42","doi-asserted-by":"publisher","unstructured":"Plouffe, S. W. et al. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell. The Journal of biological chemistry, https:\/\/doi.org\/10.1074\/jbc.RA118.002715 (2018).","DOI":"10.1074\/jbc.RA118.002715"},{"key":"42767_CR43","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1101\/gad.1664408","volume":"22","author":"B Zhao","year":"2008","unstructured":"Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes &. development 22, 1962\u20131971, https:\/\/doi.org\/10.1101\/gad.1664408 (2008).","journal-title":"development"},{"key":"42767_CR44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2005.06.007","volume":"122","author":"J Huang","year":"2005","unstructured":"Huang, J., Wu, S., Barrera, J., Matthews, K. & Pan, D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122, 421\u2013434, https:\/\/doi.org\/10.1016\/j.cell.2005.06.007 (2005).","journal-title":"Cell"},{"key":"42767_CR45","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.semcdb.2012.05.002","volume":"23","author":"M Sudol","year":"2012","unstructured":"Sudol, M., Shields, D. C. & Farooq, A. Structures of YAP protein domains reveal promising targets for development of new cancer drugs. Seminars in cell & developmental biology 23, 827\u2013833, https:\/\/doi.org\/10.1016\/j.semcdb.2012.05.002 (2012).","journal-title":"Seminars in cell & developmental biology"},{"key":"42767_CR46","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1152\/physrev.00005.2014","volume":"94","author":"S Piccolo","year":"2014","unstructured":"Piccolo, S., Dupont, S. & Cordenonsi, M. The biology of YAP\/TAZ: hippo signaling and beyond. Physiological reviews 94, 1287\u20131312, https:\/\/doi.org\/10.1152\/physrev.00005.2014 (2014).","journal-title":"Physiological reviews"},{"key":"42767_CR47","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nrgastro.2016.59","volume":"13","author":"AW Hong","year":"2016","unstructured":"Hong, A. W., Meng, Z. & Guan, K. L. The Hippo pathway in intestinal regeneration and disease. Nature reviews. Gastroenterology & hepatology 13, 324\u2013337, https:\/\/doi.org\/10.1038\/nrgastro.2016.59 (2016).","journal-title":"Gastroenterology & hepatology"},{"key":"42767_CR48","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/onc.2011.216","volume":"31","author":"T Oka","year":"2012","unstructured":"Oka, T., Schmitt, A. P. & Sudol, M. Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP. Oncogene 31, 128\u2013134, https:\/\/doi.org\/10.1038\/onc.2011.216 (2012).","journal-title":"Oncogene"},{"key":"42767_CR49","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/cdd.2008.108","volume":"15","author":"M Yuan","year":"2008","unstructured":"Yuan, M. et al. Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell death and differentiation 15, 1752\u20131759, https:\/\/doi.org\/10.1038\/cdd.2008.108 (2008).","journal-title":"Cell death and differentiation"},{"key":"42767_CR50","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/sj.onc.1208445","volume":"24","author":"EH Chan","year":"2005","unstructured":"Chan, E. H. et al. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24, 2076\u20132086, https:\/\/doi.org\/10.1038\/sj.onc.1208445 (2005).","journal-title":"Oncogene"},{"key":"42767_CR51","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao, B. et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes & development 21, 2747\u20132761, https:\/\/doi.org\/10.1101\/gad.1602907 (2007).","journal-title":"Genes & development"},{"key":"42767_CR52","doi-asserted-by":"publisher","first-page":"37159","DOI":"10.1074\/jbc.M110.152942","volume":"285","author":"CY Liu","year":"2010","unstructured":"Liu, C. Y. et al. The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase. The Journal of biological chemistry 285, 37159\u201337169, https:\/\/doi.org\/10.1074\/jbc.M110.152942 (2010).","journal-title":"The Journal of biological chemistry"},{"key":"42767_CR53","doi-asserted-by":"publisher","first-page":"21906","DOI":"10.18632\/oncotarget.4259","volume":"6","author":"Y Zhao","year":"2015","unstructured":"Zhao, Y. & Yang, X. Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling. Oncotarget 6, 21906\u201321917, https:\/\/doi.org\/10.18632\/oncotarget.4259 (2015).","journal-title":"Oncotarget"},{"key":"42767_CR54","doi-asserted-by":"publisher","first-page":"7018","DOI":"10.1074\/jbc.C110.212621","volume":"286","author":"SW Chan","year":"2011","unstructured":"Chan, S. W. et al. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. The Journal of biological chemistry 286, 7018\u20137026, https:\/\/doi.org\/10.1074\/jbc.C110.212621 (2011).","journal-title":"The Journal of biological chemistry"},{"key":"42767_CR55","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.cell.2011.02.031","volume":"144","author":"K Schlegelmilch","year":"2011","unstructured":"Schlegelmilch, K. et al. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 144, 782\u2013795, https:\/\/doi.org\/10.1016\/j.cell.2011.02.031 (2011).","journal-title":"Cell"},{"key":"42767_CR56","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/onc.2012.147","volume":"32","author":"X Liu","year":"2013","unstructured":"Liu, X. et al. PTPN14 interacts with and negatively regulates the oncogenic function of YAP. Oncogene 32, 1266\u20131273, https:\/\/doi.org\/10.1038\/onc.2012.147 (2013).","journal-title":"Oncogene"},{"key":"42767_CR57","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/cdd.2014.182","volume":"22","author":"R Keshet","year":"2015","unstructured":"Keshet, R. et al. c-Abl antagonizes the YAP oncogenic function. Cell death and differentiation 22, 935\u2013945, https:\/\/doi.org\/10.1038\/cdd.2014.182 (2015).","journal-title":"Cell death and differentiation"},{"key":"42767_CR58","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s12272-016-0821-x","volume":"39","author":"SH Min","year":"2016","unstructured":"Min, S. H., Zhou, X. Z. & Lu, K. P. The role of Pin1 in the development and treatment of cancer. Archives of pharmacal research 39, 1609\u20131620, https:\/\/doi.org\/10.1007\/s12272-016-0821-x (2016).","journal-title":"Archives of pharmacal research"},{"key":"42767_CR59","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1074\/jbc.M507026200","volume":"281","author":"A Ryo","year":"2006","unstructured":"Ryo, A. et al. Prolyl-isomerase Pin1 accumulates in lewy bodies of parkinson disease and facilitates formation of alpha-synuclein inclusions. The Journal of biological chemistry 281, 4117\u20134125, https:\/\/doi.org\/10.1074\/jbc.M507026200 (2006).","journal-title":"The Journal of biological chemistry"},{"key":"42767_CR60","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/cr.2014.109","volume":"24","author":"Z Lu","year":"2014","unstructured":"Lu, Z. & Hunter, T. Prolyl isomerase Pin1 in cancer. Cell research 24, 1033\u20131049, https:\/\/doi.org\/10.1038\/cr.2014.109 (2014).","journal-title":"Cell research"},{"key":"42767_CR61","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S1097-2765(03)00490-8","volume":"12","author":"A Ryo","year":"2003","unstructured":"Ryo, A. et al. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65\/RelA. Molecular cell 12, 1413\u20131426 (2003).","journal-title":"Molecular cell"},{"key":"42767_CR62","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/ncb0901-793","volume":"3","author":"A Ryo","year":"2001","unstructured":"Ryo, A., Nakamura, M., Wulf, G., Liou, Y. C. & Lu, K. P. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nature cell biology 3, 793\u2013801, https:\/\/doi.org\/10.1038\/ncb0901-793 (2001).","journal-title":"Nature cell biology"},{"key":"42767_CR63","doi-asserted-by":"publisher","first-page":"6109","DOI":"10.1158\/0008-5472.CAN-08-0579","volume":"68","author":"Q Ding","year":"2008","unstructured":"Ding, Q. et al. Down-regulation of myeloid cell leukemia-1 through inhibiting Erk\/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer. Cancer research 68, 6109\u20136117, https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0579 (2008).","journal-title":"Cancer research"},{"key":"42767_CR64","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00018-007-7270-0","volume":"65","author":"K Takahashi","year":"2008","unstructured":"Takahashi, K., Uchida, C., Shin, R. W., Shimazaki, K. & Uchida, T. Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer\u2019s disease. Cellular and molecular life sciences: CMLS 65, 359\u2013375, https:\/\/doi.org\/10.1007\/s00018-007-7270-0 (2008).","journal-title":"Cellular and molecular life sciences: CMLS"},{"key":"42767_CR65","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1038\/sj.emboj.7600323","volume":"23","author":"G Wulf","year":"2004","unstructured":"Wulf, G., Garg, P., Liou, Y. C., Iglehart, D. & Lu, K. P. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. The EMBO journal 23, 3397\u20133407, https:\/\/doi.org\/10.1038\/sj.emboj.7600323 (2004).","journal-title":"The EMBO journal"},{"key":"42767_CR66","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature04543","volume":"440","author":"L Pastorino","year":"2006","unstructured":"Pastorino, L. et al. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 440, 528\u2013534, https:\/\/doi.org\/10.1038\/nature04543 (2006).","journal-title":"Nature"},{"key":"42767_CR67","doi-asserted-by":"publisher","first-page":"20812","DOI":"10.1074\/jbc.M110.206904","volume":"286","author":"Y Nakatsu","year":"2011","unstructured":"Nakatsu, Y. et al. Peptidyl-prolyl cis\/trans isomerase NIMA-interacting 1 associates with insulin receptor substrate-1 and enhances insulin actions and adipogenesis. The Journal of biological chemistry 286, 20812\u201320822, https:\/\/doi.org\/10.1074\/jbc.M110.206904 (2011).","journal-title":"The Journal of biological chemistry"},{"key":"42767_CR68","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/carcin\/bgp027","volume":"30","author":"NY Lee","year":"2009","unstructured":"Lee, N. Y. et al. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation. Carcinogenesis 30, 671\u2013681, https:\/\/doi.org\/10.1093\/carcin\/bgp027 (2009).","journal-title":"Carcinogenesis"},{"key":"42767_CR69","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/ana.24347","volume":"77","author":"SH Baik","year":"2015","unstructured":"Baik, S. H. et al. Pin1 promotes neuronal death in stroke by stabilizing Notch intracellular domain. Annals of neurology 77, 504\u2013516, https:\/\/doi.org\/10.1002\/ana.24347 (2015).","journal-title":"Annals of neurology"},{"key":"42767_CR70","doi-asserted-by":"publisher","first-page":"23294","DOI":"10.1074\/jbc.M111.313684","volume":"287","author":"ZJ Shen","year":"2012","unstructured":"Shen, Z. J. et al. Pin1 protein regulates Smad protein signaling and pulmonary fibrosis. The Journal of biological chemistry 287, 23294\u201323305, https:\/\/doi.org\/10.1074\/jbc.M111.313684 (2012).","journal-title":"The Journal of biological chemistry"},{"key":"42767_CR71","doi-asserted-by":"publisher","first-page":"7092","DOI":"10.1128\/MCB.25.16.7092-7106.2005","volume":"25","author":"RJ Ingham","year":"2005","unstructured":"Ingham, R. J. et al. WW domains provide a platform for the assembly of multiprotein networks. Molecular and cellular biology 25, 7092\u20137106, https:\/\/doi.org\/10.1128\/MCB.25.16.7092-7106.2005 (2005).","journal-title":"Molecular and cellular biology"},{"key":"42767_CR72","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/ncb3216","volume":"17","author":"F Zanconato","year":"2015","unstructured":"Zanconato, F. et al. Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth. Nature cell biology 17, 1218\u20131227, https:\/\/doi.org\/10.1038\/ncb3216 (2015).","journal-title":"Nature cell biology"},{"key":"42767_CR73","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.celrep.2015.12.104","volume":"14","author":"X Liu","year":"2016","unstructured":"Liu, X. et al. Tead and AP1 Coordinate Transcription and Motility. Cell reports 14, 1169\u20131180, https:\/\/doi.org\/10.1016\/j.celrep.2015.12.104 (2016).","journal-title":"Cell reports"},{"key":"42767_CR74","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1093\/nar\/27.9.1957","volume":"27","author":"A Komuro","year":"1999","unstructured":"Komuro, A., Saeki, M. & Kato, S. Npw38, a novel nuclear protein possessing a WW domain capable of activating basal transcription. Nucleic acids research 27, 1957\u20131965 (1999).","journal-title":"Nucleic acids research"},{"key":"42767_CR75","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1084\/jem.20111653","volume":"209","author":"M Fujii","year":"2012","unstructured":"Fujii, M. et al. TGF-beta synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. The Journal of experimental medicine 209, 479\u2013494, https:\/\/doi.org\/10.1084\/jem.20111653 (2012).","journal-title":"The Journal of experimental medicine"},{"key":"42767_CR76","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.4161\/cc.21397","volume":"11","author":"M Fujii","year":"2012","unstructured":"Fujii, M. et al. Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFbeta signaling and defects in the Hippo signaling cascade. Cell cycle 11, 3373\u20133379, https:\/\/doi.org\/10.4161\/cc.21397 (2012).","journal-title":"Cell cycle"},{"key":"42767_CR77","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1074\/jbc.M109.063826","volume":"285","author":"I Matsuura","year":"2010","unstructured":"Matsuura, I. et al. Pin1 promotes transforming growth factor-beta-induced migration and invasion. The Journal of biological chemistry 285, 1754\u20131764, https:\/\/doi.org\/10.1074\/jbc.M109.063826 (2010).","journal-title":"The Journal of biological chemistry"},{"key":"42767_CR78","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1093\/emboj\/20.13.3459","volume":"20","author":"GM Wulf","year":"2001","unstructured":"Wulf, G. M. et al. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. The EMBO journal 20, 3459\u20133472, https:\/\/doi.org\/10.1093\/emboj\/20.13.3459 (2001).","journal-title":"The EMBO journal"},{"key":"42767_CR79","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s12013-014-0274-0","volume":"71","author":"M Shi","year":"2015","unstructured":"Shi, M. et al. Pin1 is overexpressed and correlates with poor prognosis in gastric cancer. Cell biochemistry and biophysics 71, 857\u2013864, https:\/\/doi.org\/10.1007\/s12013-014-0274-0 (2015).","journal-title":"Cell biochemistry and biophysics"},{"key":"42767_CR80","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1358\/dnp.2009.22.7.1381751","volume":"22","author":"GG Xu","year":"2009","unstructured":"Xu, G. G. & Etzkorn, F. A. Pin1 as an anticancer drug target. Drug news & perspectives 22, 399\u2013407, https:\/\/doi.org\/10.1358\/dnp.2009.22.7.1381751 (2009).","journal-title":"Drug news & perspectives"},{"key":"42767_CR81","first-page":"6244","volume":"63","author":"G Ayala","year":"2003","unstructured":"Ayala, G. et al. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer research 63, 6244\u20136251 (2003).","journal-title":"Cancer research"},{"key":"42767_CR82","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1535-6108(03)00218-6","volume":"4","author":"KP Lu","year":"2003","unstructured":"Lu, K. P. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer cell 4, 175\u2013180 (2003).","journal-title":"Cancer cell"},{"key":"42767_CR83","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrc.2016.49","volume":"16","author":"XZ Zhou","year":"2016","unstructured":"Zhou, X. Z. & Lu, K. P. The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target. Nature reviews. Cancer 16, 463\u2013478, https:\/\/doi.org\/10.1038\/nrc.2016.49 (2016).","journal-title":"Nature reviews. Cancer"},{"key":"42767_CR84","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/emmm.201302909","volume":"6","author":"A Rustighi","year":"2014","unstructured":"Rustighi, A. et al. Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast. EMBO molecular medicine 6, 99\u2013119, https:\/\/doi.org\/10.1002\/emmm.201302909 (2014).","journal-title":"EMBO molecular medicine"},{"key":"42767_CR85","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1101\/gad.1903310","volume":"24","author":"I Lian","year":"2010","unstructured":"Lian, I. et al. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes & development 24, 1106\u20131118, https:\/\/doi.org\/10.1101\/gad.1903310 (2010).","journal-title":"Genes & development"},{"key":"42767_CR86","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.stemcr.2017.07.019","volume":"9","author":"X Zhou","year":"2017","unstructured":"Zhou, X., Chadarevian, J. P., Ruiz, B. & Ying, Q. L. Cytoplasmic and Nuclear TAZ Exert Distinct Functions in Regulating Primed Pluripotency. Stem cell reports 9, 732\u2013741, https:\/\/doi.org\/10.1016\/j.stemcr.2017.07.019 (2017).","journal-title":"Stem cell reports"},{"key":"42767_CR87","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1110955","volume":"309","author":"JH Hong","year":"2005","unstructured":"Hong, J. H. et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309, 1074\u20131078, https:\/\/doi.org\/10.1126\/science.1110955 (2005).","journal-title":"Science"},{"key":"42767_CR88","doi-asserted-by":"publisher","first-page":"38426","DOI":"10.18632\/oncotarget.16430","volume":"8","author":"J Yu","year":"2017","unstructured":"Yu, J. et al. TAZ induces lung cancer stem cell properties and tumorigenesis by up-regulating ALDH1A1. Oncotarget 8, 38426\u201338443, https:\/\/doi.org\/10.18632\/oncotarget.16430 (2017).","journal-title":"Oncotarget"},{"key":"42767_CR89","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/ncb1140","volume":"6","author":"X Yang","year":"2004","unstructured":"Yang, X. et al. LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1. Nature cell biology 6, 609\u2013617, https:\/\/doi.org\/10.1038\/ncb1140 (2004).","journal-title":"Nature cell biology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42767-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42767-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42767-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:56:05Z","timestamp":1671267365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42767-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,23]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42767"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42767-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,23]]},"assertion":[{"value":"22 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6394"}}